Phase I trial of concurrent chemo radiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

被引：0
|
作者：
Katori, H [1 ]
Tsukuda, M [1 ]
Ishitoya, J [1 ]
Mikami, Y [1 ]
Matsuda, H [1 ]
Tanigaki, Y [1 ]
Horiuchi, C [1 ]
Ikeda, Y [1 ]
Ono, M [1 ]
Hirose, S [1 ]
机构：
[1] Yokohama City Univ, Yokohama, Kanagawa 232, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5560
引用
收藏
页码：503S / 503S
页数：1
相关论文
共 50 条
  • [21] Induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil followed by radiotherapy with Cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A-K
    Elsaesser, W.
    Kainz, H.
    Kopp, M.
    Kornek, G.
    ONKOLOGIE, 2012, 35 : 194 - 194
  • [22] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, Felix
    Selzer, Edgar
    Berghold, Andrea
    Reinisch, Sabine
    Kapp, Karin S.
    De Vries, Alexander
    Greil, Richard
    Bachtiary, Barbara
    Tinchon, Christoph
    Anderhuber, Wolfgang
    Burian, Martin
    Kasparek, Anne-Katrin
    Elsaesser, Wolfgang
    Kainz, Herbert
    Riedl, Regina
    Kopp, Michael
    Kornek, Gabriela
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 352 - 359
  • [23] Economic evaluation of the TAX 324 trial comparing docetaxel plus cisplatin and 5-fluorouracil (TPF) versus standard treatment with cisplatin and 5-fluorouracil (PF) as induction chemotherapy followed by concurrent chemoradiation therapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Parthan, A.
    Posner, M. R.
    Brammer, C.
    Beltran, P.
    Jansen, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Phase I-II study with docetaxel (D), cisplatin (C) and 5-Fluorouracil (5-FU) in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Brandely, M
    Vermorken, JB
    ANNALS OF ONCOLOGY, 1998, 9 : 75 - 75
  • [25] Phase I-II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Le Bouder, C
    Castelijns, J
    Awada, A
    Vermorken, JB
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S164 - S164
  • [26] Results of a randomized phase II trial of docetaxel (TXT) with cisplatin (CDDP) or TXT with 5-fluorouracil (5FU) in patients (pts) with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Biakhov, M
    Betka, J
    Shah, P
    Julka, P
    Garin, A
    Stanculaneu, D
    Kawecki, A
    Miserque, D
    Blanc, C
    ANNALS OF ONCOLOGY, 2000, 11 : 92 - 92
  • [27] Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck
    Tsukuda, Mamoru
    Ishitoya, Junichi
    Matsuda, Hideki
    Horiuchi, Choichi
    Taguchi, Takahide
    Takahashi, Masahiro
    Nishimura, Goshi
    Kawakami, Mariko
    Watanabe, Makiko
    Niho, Tatsuo
    Kawano, Toshiro
    Ikeda, Yoichi
    Sakuma, Yasunori
    Shiono, Osamu
    Komatsu, Masanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 729 - 736
  • [28] Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
    Fayette, Jerome
    Fontaine-Delaruelle, Clara
    Ambrun, Alexis
    Daveau, Clementine
    Poupart, Marc
    Ramade, Antoine
    Zrounba, Philippe
    Neidhardt, Eve-Marie
    Peron, Julien
    Diallo, Alpha
    Ceruse, Philippe
    ONCOTARGET, 2016, 7 (24) : 37297 - 37304
  • [29] Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck
    Mamoru Tsukuda
    Junichi Ishitoya
    Hideki Matsuda
    Choichi Horiuchi
    Takahide Taguchi
    Masahiro Takahashi
    Goshi Nishimura
    Mariko Kawakami
    Makiko Watanabe
    Tatsuo Niho
    Toshiro Kawano
    Yoichi Ikeda
    Yasunori Sakuma
    Osamu Shiono
    Masanori Komatsu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 729 - 736
  • [30] Docetaxel and cisplatin concurrent with radiotherapy versus 5-fluorouracil and cisplatin concurrent with radiotherapy in treatment for locally advanced oesophageal squamous cell carcinoma: a randomized clinical study
    Tao Zhao
    Hao Chen
    Tingrong Zhang
    Medical Oncology, 2012, 29 : 3017 - 3023
12345